Skip to main content

Table 3 Associated comorbidities in Italian fibromyalgia patients treated with medical cannabis

From: Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series

Comorbidities

N = 38

Patients

%

Hypovitaminosis D with or without osteoporosis/osteopenia

17

44.7

Hypertension

15

39.5

Depression

12

31.6

Osteoarthritis

11

28.9

Hiatal hernia

8

21.1

Hypothyroidism

6

15.8

Hypercholesterolemia

6

15.8

Tachycardia/atrial fibrillation

4

10.5

Irritable colon

4

10.5

Diabetes

4

10.5

Hyperuricemia

4

10.5

Psoriasis

3

7.9

Carpal tunnel syndrome

3

7.9

Raynaud syndrome

3

7.9

Pulmonary thromboembolism

2

5.3

Liver disease

2

5.3

Glaucoma

2

5.3

Endometriosis

2

5.3

Kidney failure

1

2.6

Ischemic heart disease

1

2.6

Skin fungus

1

2.6

Vasculopathy

1

2.6

Anemia

1

2.6

OSAS

1

2.6

Duodenal ulcer

1

2.6

Sjogren syndrome

1

2.6

  1. N number of patients, OSAS obstructive sleep apnea syndrome. Comorbidities of 38 patients with fibromyalgia syndrome treated with medical cannabis at an Italian pain clinic